Suppr超能文献

用于透皮给药的硫代秋水仙苷富含欧米伽3脂肪酸的纳米乳剂:制剂、表征及吸收研究

Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.

作者信息

Kumar Dinesh, Ali Javed, Baboota Sanjula

机构信息

a Faculty of Pharmacy, Department of Pharmaceutics , Hamdard University , Hamdard Nagar , New Delhi , India.

出版信息

Drug Deliv. 2016;23(2):591-600. doi: 10.3109/10717544.2014.916764. Epub 2014 Jun 3.

Abstract

Thiocolchicoside (TCC) is an effective therapeutic agent against the orthopaedic, traumatic and rheumatologic disorders but it suffer from the drawback of poor bioavailability due to extensive first pass metabolism and low permeability via the oral route. The aim of the present study was to evaluate the potential of nanoemulsion (NE) for bioavailability enhancement of TCC through the transdermal route. The NEs were developed using Linseed: sefsol in 1:1 ratio as the oil phase, span 80, Transcutol P and distilled water as surfactant, co-surfactant and aqueous phase. Furthermore, selected formulations were subjected to physical stability and consequently evaluated for in vitro permeation using porcine skin. The optimized formulation had small average globule diameter of 117 nm with polydispersity index of 0.285. The globules were spherical in shape as observed by transmission electron microscopy. The in vitro skin permeation profile of optimized NE was compared with aqueous solution of TCC. Significant increase in permeability parameters were observed in NEs formulation (p < 0.05) as compared to aqueous solution of TCC. The steady-state flux (Jss) and permeability coefficient (Kp) for optimized NE formulation (C1) were found to be 30.63 ± 4.18 µg/cm(2)/h and 15.21 × 10(-3) ± 2.81cm(2)/h, respectively. The results of enhanced permeation through transdermal route suggest that water-in-oil NEs which are compatible with the lipophilic sebum environment of the hair follicle facilitate the transport of TCC, and such transport might be predominantly transfollicular in nature. Overall, these results suggested that water-in-oil NEs are good carriers for transdermal delivery of TCC.

摘要

硫代秋水仙苷(TCC)是一种治疗骨科、创伤和风湿性疾病的有效治疗剂,但由于广泛的首过代谢和口服途径的低渗透性,它存在生物利用度差的缺点。本研究的目的是评估纳米乳剂(NE)通过透皮途径提高TCC生物利用度的潜力。以亚麻籽:sefsol 1:1比例作为油相,司盘80、Transcutol P和蒸馏水作为表面活性剂、助表面活性剂和水相来制备纳米乳剂。此外,对选定的制剂进行物理稳定性测试,并使用猪皮进行体外渗透评估。优化后的制剂平均球径小,为117 nm,多分散指数为0.285。通过透射电子显微镜观察,球粒呈球形。将优化后的纳米乳剂的体外皮肤渗透曲线与TCC水溶液进行比较。与TCC水溶液相比,纳米乳剂制剂的渗透参数有显著增加(p < 0.05)。优化后的纳米乳剂制剂(C1)的稳态通量(Jss)和渗透系数(Kp)分别为30.63±4.18 μg/cm²/h和15.21×10⁻³±2.81 cm²/h。通过透皮途径增强渗透的结果表明,与毛囊亲脂性皮脂环境相容的油包水纳米乳剂促进了TCC的转运,并且这种转运可能主要是经毛囊性质的。总体而言,这些结果表明油包水纳米乳剂是TCC透皮给药的良好载体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验